{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:21:18Z","timestamp":1792920078811,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005771","name":"Dokuz Eyl\u00fcl \u00dcniversitesi","doi-asserted-by":"publisher","award":["KB.SAG.023"],"award-info":[{"award-number":["KB.SAG.023"]}],"id":[{"id":"10.13039\/501100005771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.msard.2022.104149","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T12:08:02Z","timestamp":1661688482000},"page":"104149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Epstein\u2013Barr virus antibody in newly diagnosed multiple sclerosis patients and its association with relapse severity and lesion location"],"prefix":"10.1016","volume":"68","author":[{"given":"Onder","family":"Olmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cavid","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhal","family":"Abasiyanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Ozakbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/j.msard.2022.104149_bib0001","doi-asserted-by":"crossref","first-page":"11292","DOI":"10.1073\/pnas.1811974115","article-title":"Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis","volume":"115","author":"Leibovitch","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"14","key":"10.1016\/j.msard.2022.104149_bib0002","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1177\/1352458514533843","article-title":"Antibodies to Epstein\u2013Barr virus and MRI disease activity in multiple sclerosis","volume":"20","author":"Kvistad","year":"2014","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2022.104149_bib0003","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.104149_bib0004","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1073\/pnas.0404874101","article-title":"Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines","volume":"101","author":"Hohlfeld","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6578","key":"10.1016\/j.msard.2022.104149_bib0005","first-page":"296","article-title":"Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science (1979)"},{"issue":"1","key":"10.1016\/j.msard.2022.104149_bib0006","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.202048655","article-title":"Attenuated immune control of Epstein\u2013Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15","volume":"51","author":"Zdimerova","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"22","key":"10.1016\/j.msard.2022.104149_bib0007","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.1128\/JVI.01699-12","article-title":"Persistence of Epstein\u2013Barr virus in self-reactive memory B cells","volume":"86","author":"Tracy","year":"2012","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.msard.2022.104149_bib0008","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ni835","article-title":"A functional and structural basis for TCR cross-reactivity in multiple sclerosis","volume":"3","author":"Lang","year":"2002","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2022.104149_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012496","article-title":"An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"Handel","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.msard.2022.104149_bib0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.104149_bib0011","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1093\/brain\/awr197","article-title":"Group the NEBVW, Epstein\u2013Barr virus in the multiple sclerosis brain: a controversial issue report on a focused workshop held in the centre for brain research of the medical university of Vienna, Austria","volume":"134","author":"Lassmann","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2022.104149_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.25119","article-title":"B-cell therapy for multiple sclerosis: entering an era","volume":"83","author":"Greenfield","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2022.104149_bib0013","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Ann. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2022.104149_bib0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12974-017-1049-5","article-title":"Transcriptional profile and Epstein\u2013Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis","volume":"15","author":"Veroni","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2022.104149_bib0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2022.104149_bib0016","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.176.6.3498","article-title":"Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells","volume":"176","author":"Crawford","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2022.104149_bib0017","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.55.2.178","article-title":"Association between clinical disease activity and Epstein\u2013Barr virus reactivation in MS","volume":"55","author":"Wandinger","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2022.104149_bib0018","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2022.104149_bib0019","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0404.2004.00246.x","article-title":"Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria","volume":"109","author":"Fangerau","year":"2004","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.msard.2022.104149_bib0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.msard.2022.104149_bib0021","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2022.104149_bib0022","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/135245859900500409","article-title":"The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. national MS society clinical outcomes assessment task force","volume":"5","author":"Fischer","year":"1999","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2022.104149_bib0023","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12883-017-0993-0","article-title":"The Turkish validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) battery","volume":"17","author":"Ozakbas","year":"2017","journal-title":"BMC Neurol."},{"issue":"10","key":"10.1016\/j.msard.2022.104149_bib0024","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/jnnp.2004.048504","article-title":"Epstein\u2013Barr virus and disease activity in multiple sclerosis","volume":"76","author":"Buljevac","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.104149_bib0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0074-7742(07)79019-0","article-title":"Prognostic factors in multiple sclerosis","volume":"79","author":"Bergamaschi","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"issue":"1","key":"10.1016\/j.msard.2022.104149_bib0026","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","article-title":"Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI","volume":"73","author":"Farrell","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2022.104149_bib0027","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1212\/NXI.0000000000000190","article-title":"Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS","volume":"3","author":"Zivadinov","year":"2016","journal-title":"Neurol.(R) Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.msard.2022.104149_bib0028","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s00415-019-09589-2","article-title":"Early MRI predictors of prognosis in multiple sclerosis","volume":"266","author":"Davda","year":"2019","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2022.104149_bib0029","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.20832","article-title":"Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?","volume":"59","author":"Goodin","year":"2006","journal-title":"Ann. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822006563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822006563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:28:48Z","timestamp":1778840928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822006563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"alternative-id":["S2211034822006563"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104149","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein\u2013Barr virus antibody in newly diagnosed multiple sclerosis patients and its association with relapse severity and lesion location","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104149"}}